← Back to Search

Ablative Therapy

Ablative Techniques for Endometriosis

N/A
Recruiting
Research Sponsored by TriHealth Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adult women 18 years of age or older already planning to undergo scheduled robotic assisted or laparoscopic excision of lesions for pelvic pain symptoms (pelvic pain, dysmenorrhea, dyspareunia, dysuria, dyschezia, ovarian pain) or endometriosis of any kind (endometriosis of any location, or endometrioma)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aimed to compare different technologies used to destroy endometriosis tissue in humans, as no other studies have directly compared their effectiveness.

Who is the study for?
This trial is for adult women aged 18 or older who are scheduled for robotic assisted or laparoscopic surgery to remove endometriosis lesions due to pelvic pain symptoms. It's not open to pregnant women at the time of enrollment or surgery.
What is being tested?
The study compares three different techniques used in surgery to destroy endometriosis tissue: Diathermy, CO2 Laser, and Argon Beam Coagulator. The goal is to find out which method is most effective.
What are the potential side effects?
Potential side effects may include discomfort at the site of ablation, bleeding, infection risk from surgical procedures, and possible damage to surrounding tissues.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a woman over 18 planning surgery for pelvic pain or endometriosis.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Positive Histology
Secondary study objectives
Pelvic Pain

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Active Control
Group I: DiathermyActive Control1 Intervention
Group II: Argon Beam CoagulatorActive Control1 Intervention
Group III: CO2 LaserActive Control1 Intervention

Find a Location

Who is running the clinical trial?

TriHealth Inc.Lead Sponsor
99 Previous Clinical Trials
53,672 Total Patients Enrolled
~59 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top